<![CDATA[
What Is IHHT Therapy?
Intermittent Hypoxia-Hyperoxia Training (IHHT) is an innovative regenerative therapy that harnesses the body’s natural adaptive response to varying oxygen levels. Sometimes described as “altitude training at rest,” IHHT delivers carefully controlled cycles of low-oxygen (hypoxic) and high-oxygen (hyperoxic) air through a comfortable breathing mask while the patient reclines in a relaxed position.
Unlike traditional altitude training used by elite athletes, IHHT does not require physical exertion. The therapeutic benefit arises from the body’s cellular response to fluctuating oxygen concentrations — a process that triggers profound changes at the mitochondrial level. At St. George Hospital in Bad Aibling, Germany, IHHT is integrated into our comprehensive treatment protocols for patients dealing with chronic fatigue, post-COVID syndrome, and age-related decline.
The Science Behind IHHT: Mitochondrial Biogenesis
Mitochondria are the energy-producing organelles within every cell. As we age or suffer from chronic illness, mitochondrial function declines — damaged mitochondria accumulate, energy production falters, and cellular repair mechanisms slow. This mitochondrial dysfunction is now recognized as a central driver of fatigue, cognitive decline, and chronic disease progression.
IHHT works by exploiting a fundamental biological principle: controlled physiological stress triggers adaptive repair. When the body experiences brief periods of reduced oxygen (hypoxia), it activates a transcription factor known as Hypoxia-Inducible Factor 1-alpha (HIF-1α). This molecular signal initiates a cascade of beneficial processes:
- Selective mitophagy: The body identifies and eliminates damaged, inefficient mitochondria
- Mitochondrial biogenesis: New, healthy mitochondria are generated to replace those removed
- Enhanced oxygen utilization: Remaining mitochondria become more efficient at producing ATP (cellular energy)
- Improved antioxidant defense: Upregulation of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase
The hyperoxic phases between hypoxic intervals accelerate recovery and enhance the overall training effect. A 2020 study published in Frontiers in Physiology demonstrated that IHHT significantly improved mitochondrial respiratory capacity in patients with metabolic syndrome, lending further support to its clinical applications.
Who Benefits from IHHT Therapy?
IHHT therapy is particularly valuable for patients experiencing conditions rooted in mitochondrial dysfunction or impaired cellular energy metabolism. At St. George Hospital, Dr. Julian Douwes and our medical team recommend IHHT as part of individualized treatment programs for:
Chronic Fatigue and Post-COVID Syndrome
Patients recovering from post-COVID syndrome frequently present with persistent fatigue, brain fog, and exercise intolerance — all hallmarks of mitochondrial impairment. IHHT can help restore cellular energy production, gradually improving stamina and cognitive clarity. Similarly, patients with chronic fatigue syndrome (ME/CFS) often demonstrate measurable mitochondrial dysfunction that IHHT directly addresses.
Age-Related Decline and Longevity
Mitochondrial deterioration is one of the recognized hallmarks of biological aging. For patients pursuing longevity and healthy aging, IHHT offers a non-pharmacological approach to rejuvenating cellular energy systems. Research suggests that IHHT may improve cardiovascular fitness, metabolic markers, and cognitive performance in older adults.
Metabolic Conditions
Patients with insulin resistance, metabolic syndrome, or type 2 diabetes may benefit from IHHT’s effects on glucose metabolism and lipid profiles. A study in the International Journal of Environmental Research and Public Health found that IHHT improved fasting glucose levels and reduced inflammatory markers in metabolic syndrome patients.
Neurodegenerative and Neurological Conditions
Emerging evidence suggests IHHT may support neuroprotection by improving cerebral blood flow and reducing oxidative stress in brain tissue. While research is ongoing, early clinical observations indicate potential benefits for patients with early-stage cognitive decline.
Athletic Recovery and Performance
Although our primary focus is clinical medicine, IHHT has well-documented applications in sports medicine. The therapy enhances oxygen-carrying capacity, improves VO2 max, and accelerates recovery from physical stress — benefits that also translate to patients rebuilding physical capacity after prolonged illness.
What Happens During an IHHT Session?
An IHHT session at St. George Hospital follows a carefully structured protocol designed for safety and therapeutic efficacy:
Pre-Treatment Assessment
Before beginning IHHT, each patient undergoes a comprehensive evaluation including baseline oxygen saturation measurements, cardiovascular assessment, and — where indicated — mitochondrial function testing through our diagnostic laboratory. This assessment helps determine the appropriate oxygen concentrations and session parameters for the individual patient.
The Session Protocol
- Preparation: The patient reclines comfortably in a treatment chair. A pulse oximeter is attached for continuous monitoring of blood oxygen saturation and heart rate.
- Mask application: A soft breathing mask is fitted, connected to the IHHT device that precisely controls inspired oxygen concentrations.
- Hypoxic intervals: The patient breathes air with reduced oxygen concentration (typically 10–15% O₂, compared to the normal 21%) for 3–5 minutes. During this phase, oxygen saturation is carefully monitored and maintained within safe therapeutic ranges.
- Hyperoxic intervals: The oxygen concentration is then increased above normal levels (30–40% O₂) for 1–3 minutes, allowing rapid recovery and enhanced adaptation.
- Cycling: These alternating phases are repeated for 30–40 minutes per session, typically delivering 5–8 complete cycles.
- Recovery: The session concludes with a normoxic (normal air) breathing period while vital signs are recorded.
Treatment Course
A standard IHHT treatment course consists of 10–15 sessions, typically administered 3–5 times per week. Many patients report noticeable improvements in energy levels and mental clarity within the first week of treatment. Optimal results generally emerge after completing the full course, with benefits that can persist for several months.
IHHT at St. George Hospital: Our Integrative Approach
At St. George Hospital, we rarely prescribe IHHT as a standalone intervention. Under the direction of Dr. Julian Douwes, IHHT is integrated into comprehensive treatment programs that may include:
- NAD+ intravenous therapy to further support mitochondrial function
- Ozone therapy for enhanced oxygen utilization and immune modulation
- Targeted micronutrient infusions (coenzyme Q10, L-carnitine, B vitamins) that serve as essential mitochondrial cofactors
- Individualized exercise guidance to complement the cellular benefits of IHHT
This integrative approach ensures that the mitochondrial renewal stimulated by IHHT is supported at every level — from cofactor availability to systemic detoxification.
Safety and Contraindications
IHHT is generally well-tolerated, with a favorable safety profile when administered under medical supervision. The controlled nature of the oxygen fluctuations means the body is never subjected to dangerous levels of hypoxia. Continuous pulse oximetry monitoring ensures patient safety throughout each session.
However, IHHT may not be appropriate for all patients. Relative contraindications include:
- Severe, uncontrolled cardiac arrhythmias
- Acute febrile infections
- Severe anemia (hemoglobin below 8 g/dL)
- Uncontrolled epilepsy
- Advanced COPD with resting hypoxemia
Our medical team evaluates each patient individually to determine whether IHHT is safe and appropriate within their overall treatment plan.
Evidence Base for IHHT Therapy
While IHHT is still emerging in mainstream Western medicine, its scientific foundation is robust. The physiological principles of intermittent hypoxic training have been studied extensively in aerospace medicine, sports science, and increasingly in clinical settings. Key areas of published research include:
- Improved mitochondrial respiratory chain function in metabolic syndrome patients
- Enhanced cognitive performance in elderly subjects following IHHT courses
- Significant improvements in exercise tolerance and cardiovascular parameters
- Reduction in systemic inflammatory markers (CRP, IL-6)
A comprehensive review published in Aging and Disease summarized the neuroprotective and cardioprotective potential of intermittent hypoxia-hyperoxia conditioning, supporting its clinical application in age-related and chronic diseases.
It is important to note that while clinical evidence is growing, IHHT remains an area of active research. At St. George Hospital, we apply this therapy within evidence-informed protocols and monitor patient outcomes carefully.
Frequently Asked Questions About IHHT Therapy
Is IHHT therapy the same as hyperbaric oxygen therapy?
No. Hyperbaric oxygen therapy (HBOT) delivers high-pressure oxygen in a sealed chamber, while IHHT alternates between low-oxygen and high-oxygen breathing at normal atmospheric pressure. The mechanisms of action are fundamentally different — IHHT specifically targets mitochondrial turnover through controlled hypoxic stress, whereas HBOT primarily increases tissue oxygen saturation. Both therapies have valid clinical applications, but they address different aspects of cellular physiology.
How many IHHT sessions do I need to see results?
Most patients begin to notice improvements in energy and mental clarity within the first 5–7 sessions. A standard treatment course is 10–15 sessions over 2–4 weeks. The full benefits of mitochondrial biogenesis typically manifest over the weeks following the completed course, as newly generated mitochondria mature and integrate into cellular function. Your physician will tailor the treatment plan based on your specific condition and response.
Can IHHT be combined with other therapies?
Absolutely. At St. George Hospital, IHHT is typically prescribed as part of an integrative treatment program. It pairs particularly well with NAD+ infusions, ozone therapy, and targeted micronutrient supplementation — all of which support mitochondrial health through complementary mechanisms. Dr. Julian Douwes designs individualized protocols that leverage these synergies for optimal outcomes.
Is IHHT suitable for elderly patients?
Yes, IHHT is generally well-suited for older adults, who stand to benefit significantly from mitochondrial renewal. The therapy requires no physical exertion, making it accessible even for patients with limited mobility or exercise tolerance. Age-appropriate oxygen parameters are carefully calibrated, and continuous monitoring ensures safety throughout each session.
Are there any side effects of IHHT therapy?
Side effects are uncommon and typically mild. Some patients experience transient light-headedness during hypoxic intervals, which resolves immediately when oxygen levels are restored. Occasional mild headache or drowsiness after a session has been reported, usually only during the first one or two treatments as the body adapts. Serious adverse events are extremely rare when the therapy is administered by trained medical personnel with appropriate monitoring.
Begin Your IHHT Treatment at St. George Hospital
If you are living with chronic fatigue, post-COVID symptoms, or age-related decline, IHHT therapy may offer a meaningful path toward cellular renewal and improved quality of life. At St. George Hospital, we combine this innovative treatment with decades of experience in integrative medicine to deliver comprehensive, physician-supervised care.
To learn whether IHHT is appropriate for your situation, contact our international patient coordination team:
- Phone: +49 (0)8061 398-0
- Email: info@clinicum-stgeorg.de
- Online: Request a consultation
This article is intended for informational purposes only and does not constitute medical advice. IHHT therapy should be administered under qualified medical supervision. Individual results may vary.
]]>